Jacob Van Naarden
Equibles does not estimate personal net worth.
Get an email with a short summary when ELI LILLY & Co publishes a filing, an earnings call transcript or a press release.
Get LLY alertsAbout Jacob Van Naarden
Jacob Van Naarden is recorded as CEO at ELI LILLY & Co (LLY). The proxy statement of ELI LILLY & Co reports total compensation of $6,122,742 for Jacob Van Naarden in fiscal 2021, including a base salary of $745,649. ELI LILLY & Co is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at ELI LILLY & Co includes Juan Luciano (CEO), David Ricks (Chairman and Board Member), Kimberly Johnson (COO) and 6 others.
Affiliation history
-
Current
Company network
Leadership on record at ELI LILLY & Co
- Juan Luciano CEO
- David Ricks Chairman, Board Member
- Kimberly Johnson COO
- Anat Hakim General Counsel
- Carolyn Bertozzi Board Member
- Carolyn R. Bertozzi Board Member
- Dr. Mary Lynne Hedley Board Member
- Jon Moeller Board Member
- William Kaelin Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | ELI LILLY & Co (LLY) | Senior Vice President, CEO Loxo Oncology at Lilly and President, Lilly Oncology | $745,649 | $6,122,742 |
Recent activity
No call appearances or filed executive changes recorded yet.